©2025 Bryn Mawr Communications, LLC.
All Rights Reserved

Terms and Conditions • Privacy Policy

Drug Selection and Patient Outcomes in AMD

David Eichenbaum, MD

Show Description +

David Eichenbaum, MD, demonstrates how drug selection can affect outcomes over time by sharing the cases of two patients with age-related macular degeneration.

Posted: 5/17/2016

Keywords:

Age-Related Macular Degeneration (AMD)

•

AMD Disease Education Resource Center

•

Regeneron Pharmaceuticals

•

Wet AMD

Drug Selection and Patient Outcomes in AMD

David Eichenbaum, MD

David Eichenbaum, MD, demonstrates how drug selection can affect outcomes over time by sharing the cases of two patients with age-related macular degeneration.

Posted: 5/17/2016

Keywords:

Age-Related Macular Degeneration (AMD)

•

AMD Disease Education Resource Center

•

Regeneron Pharmaceuticals

•

Wet AMD

Please log in to leave a comment.

close-x